Aziz Sawaf
Executive VP, CFO & Principal Financial OfficerMr. Aziz Sawaf, MBEE, MBA, CFA, is Executive VP, CFO & Principal Financial Officer of Vir Biotechnology, Inc. from October 5, 2026. He was CFO of Theravance Biopharma, Inc. from January 2023 and was its Senior Vice President of Operations Strategy since March 2025. Mr. Sawaf served as Senior Vice President of Theravance Biopharma, Inc. from January 2023 to March 2025. Previously, Mr. Sawaf was Vice President of Finance and a member of the Senior Leadership Team from October 2021 to December 2022, having joined company in June 2014 and serving in various roles of increasing responsibility across the finance organization. Prior to Theravance Biopharma, Mr. Sawaf was at Gilead Sciences, working in several Finance roles supporting the Commercial and R&D organizations. Prior to Gilead Sciences, Mr. Sawaf worked at Amgen, in Consulting and in internet start-up Finance. Mr. Sawaf holds a B.S. in Business Administration, Finance, from the University of Arizona, an M.B.A. from the University of Southern California Marshall School of Business and a Master of Biotechnology Enterprise and Entrepreneurship (M.B.E.E.) from Johns Hopkins University. Mr. Sawaf has been a CFA charterholder since 2013 and is a Board Member of the California Life Sciences Association (CLS).
Positions
- Company NameVir Biotechnology, Inc.Stock CodeVIRPositionExecutive VP, CFO & Principal Financial Officer
